These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33587766)

  • 1. Rapidly progressive alopecia areata totalis in a COVID-19 patient, unresponsive to tofacitinib.
    Berbert Ferreira S; Gavazzoni Dias MFR; Berbert Ferreira R; Neves Neto AC; Trüeb RM; Lupi O
    J Eur Acad Dermatol Venereol; 2021 Jul; 35(7):e411-e412. PubMed ID: 33587766
    [No Abstract]   [Full Text] [Related]  

  • 2. Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.
    Liu LY; Craiglow BG; Dai F; King BA
    J Am Acad Dermatol; 2017 Jan; 76(1):22-28. PubMed ID: 27816293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Alopecia Areata With Tofacitinib.
    Ibrahim O; Bayart CB; Hogan S; Piliang M; Bergfeld WF
    JAMA Dermatol; 2017 Jun; 153(6):600-602. PubMed ID: 28355451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers.
    Jabbari A; Nguyen N; Cerise JE; Ulerio G; de Jong A; Clynes R; Christiano AM; Mackay-Wiggan J
    Exp Dermatol; 2016 Aug; 25(8):642-3. PubMed ID: 27119625
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
    Cheng MW; Kehl A; Worswick S; Goh C
    J Drugs Dermatol; 2018 Jul; 17(7):800-803. PubMed ID: 30005104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tofacitinib therapy for children with severe alopecia areata.
    Dai YX; Chen CC
    J Am Acad Dermatol; 2019 Apr; 80(4):1164-1166. PubMed ID: 30630026
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical tofacitinib in treatment of alopecia areata.
    Ferreira SB; Ferreira RB; Scheinberg MA
    Einstein (Sao Paulo); 2020; 18():eAI5452. PubMed ID: 32785452
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment outcome of oral tofacitinib and ruxolitinib in patients with alopecia areata: A systematic review and meta-analysis.
    Yu DA; Kim YE; Kwon O; Park H
    Indian J Dermatol Venereol Leprol; 2021; 87(5):621-627. PubMed ID: 34379968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.
    Sedano R; Jairath V
    Inflamm Bowel Dis; 2021 Apr; 27(5):e65. PubMed ID: 33484124
    [No Abstract]   [Full Text] [Related]  

  • 10. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
    Almutairi N; Nour TM; Hussain NH
    Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman.
    Mrowietz U; Gerdes S; Gläser R; Schröder O
    Acta Derm Venereol; 2017 Feb; 97(2):283-284. PubMed ID: 27349217
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of the alopecia areata patients on tofacitinib treatment during the COVID-19 pandemic.
    Aşkın Ö; Özkoca D; Uzunçakmak TK; Serdaroğlu S
    Dermatol Ther; 2021 Mar; 34(2):e14746. PubMed ID: 33405372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alopecia universalis unresponsive to treatment with tofacinitib: report of a case with a brief review of the literature.
    Salman A; Sarac G; Ergun T
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with insurance coverage of tofacitinib for alopecia areata: A retrospective review from an academic institution.
    Thompson HJ; Vavra T; Jabbari A
    J Am Acad Dermatol; 2020 Nov; 83(5):1509-1510. PubMed ID: 32553634
    [No Abstract]   [Full Text] [Related]  

  • 15. Tofacitinib for the treatment of alopecia areata and variants in adolescents.
    Craiglow BG; Liu LY; King BA
    J Am Acad Dermatol; 2017 Jan; 76(1):29-32. PubMed ID: 27816292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral tofacitinib for successful treatment of refractory alopecia areata in preschool children.
    Geng SL; Gong T; Ji C; Su HH
    J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e1055-e1057. PubMed ID: 35876014
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic synergy between contact dermatitis from a wig-fixing device and tofacitinib on alopecia areata.
    Lee JS; Yoon HS; Cho S; Park HS
    J Dermatol; 2019 Apr; 46(4):e139-e140. PubMed ID: 30204259
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination tofacitinib and oral minoxidil treatment for severe alopecia areata.
    Wambier CG; Craiglow BG; King BA
    J Am Acad Dermatol; 2021 Sep; 85(3):743-745. PubMed ID: 31499158
    [No Abstract]   [Full Text] [Related]  

  • 19. Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents.
    Liu LY; King BA
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S18-S20. PubMed ID: 29273099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.